These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production. Bao W; Behm DJ; Nerurkar SS; Ao Z; Bentley R; Mirabile RC; Johns DG; Woods TN; Doe CP; Coatney RW; Ohlstein JF; Douglas SA; Willette RN; Yue TL J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension. Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486 [TBL] [Abstract][Full Text] [Related]
7. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Daugherty A; Rateri DL; Lu H; Inagami T; Cassis LA Circulation; 2004 Dec; 110(25):3849-57. PubMed ID: 15596561 [TBL] [Abstract][Full Text] [Related]
8. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Schrader LI; Kinzenbaw DA; Johnson AW; Faraci FM; Didion SP Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2576-81. PubMed ID: 17962626 [TBL] [Abstract][Full Text] [Related]
9. Impaired endothelium-dependent responses and enhanced influence of Rho-kinase in cerebral arterioles in type II diabetes. Didion SP; Lynch CM; Baumbach GL; Faraci FM Stroke; 2005 Feb; 36(2):342-7. PubMed ID: 15637328 [TBL] [Abstract][Full Text] [Related]
10. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis. Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558 [TBL] [Abstract][Full Text] [Related]